Clinical Trials

Biomarker development for predicting immune checkpoint therapy efficacy of hepatocellular carcinoma (CTMS# 22-0050)

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Sukeshi Patel Arora MD

For more information about this study
View Details

About This Study

We propose to test whether H1 and H2 clustering can distinguish patients responsive or resistant to the combination therapy with immunotherapy in a prospective clinical study.